XML 28 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
DERIVATIVE FINANCIAL INSTRUMENTS
3 Months Ended
Mar. 31, 2012
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments And Hedging Activities Disclosure [Text Block]

NOTE G – DERIVATIVE FINANCIAL INSTRUMENTS

 

The Company may, at times, use derivative financial instruments to manage its interest rate risk. These instruments carry varying degrees of credit, interest rate, and market or liquidity risks. Derivative instruments are recognized as either assets or liabilities in the consolidated financial statements and are measured at fair value. Subsequent changes in the derivatives’ fair values are recognized in earnings unless specific hedge accounting criteria are met. The Predecessor Company entered into certain interest rate swap agreements as described below.

 

In August 2003, $8.0 million in trust preferred securities (“TRUPs”) were issued through Crescent Financial Capital Trust I (the “Trust”). The Trust invested the total proceeds from the sale of its TRUPs in junior subordinated deferrable interest debentures issued by the Company, which fully and unconditionally guarantees the TRUPs. The junior subordinated debentures were adjusted to estimated fair value in purchase accounting with the Piedmont Investment, and at March 31, 2012, their carrying value was $5.5 million. The TRUPs pay cumulative cash distributions quarterly at an annual contract rate, reset quarterly, equal to three-month LIBOR plus 3.10%.

 

In June 2009, the Company entered into derivative financial instruments which swapped the variable rate payments for fixed payments. These instruments consisted of a three-year and four-year swap, each for one-half of the notional amount of the TRUPs for fixed rates of 5.49% and 5.97%, respectively. Due to the deferral of interest payments on the TRUPs, the associated interest rate swaps no longer qualify for cash flow hedge accounting and are therefore marked to fair value through earnings.

 

On September 26, 2008, the Bank entered into an unsecured subordinated term loan agreement in the amount of $7.5 million. The agreement requires the Bank to make quarterly payments of interest at an annual contract rate, reset quarterly, equal to three-month LIBOR plus 4.00%. The subordinated term loan was adjusted to estimated fair value in purchase accounting with the Piedmont Investment, and at March 31, 2012, its carrying value was $6.8 million.

 

In June 2009, the Bank entered into derivative financial instruments which swapped the variable rate payments for fixed payments. These instruments consisted of a three-year and four-year swap, each for one-half of the notional amount of the subordinated debt for fixed rates of 6.39% and 6.87%, respectively. At the Piedmont Investment, these swaps were no longer designated as qualifying for hedge accounting and therefore mark them to fair value through earnings.

 

The following tables disclose the location and fair value amounts of derivative instruments designated as hedging instruments in the consolidated balance sheets.

        March 31,     December 31,  
        2012     2011  
  Balance Sheet   Notional     Estimated Fair     Estimated Fair  
  Location   Amount     Value     Value  
Trust preferred securities:                    
Interest rate swap   Other liabilities   $ 4,000,000     $ (21,453 )   $ (38,275 )
Interest rate swap   Other liabilities     4,000,000       (121,638 )     (134,029 )
                             
Subordinated term loan agreements:                            
Interest rate swap   Other liabilities     3,750,000       (18,575 )     (34,160 )
Interest rate swap   Other liabilities     3,750,000       (112,259 )     (123,650 )
                             
        $ 15,500,000     $ (273,925 )   $ (330,114 )

 

The following table discloses activity in accumulated other comprehensive income (“OCI”) related to the interest rate swaps for the periods presented.

    Successor Company     Predecessor Company  
    January 1     January 1  
    to     to  
    March 31,     March 31,  
    2012     2011  
Accumulated OCI resulting from  interest rate swaps as of the beginning of the period, net of tax   $ -     $ (355,818 )
Other comprehensive (gain) loss recognized, net of tax     -       49,190  
                 
Accumulated OCI resulting from interest rate  swaps as of the end of the period, net of tax   $ -     $ (306,628 )

 

The Company monitors the credit risk of the interest rate swap counterparty. The Company has pledged $780,000 in cash to the counterparty to the swaps.